2020
DOI: 10.1016/j.bioorg.2020.104011
|View full text |Cite
|
Sign up to set email alerts
|

A Pt(IV)-based mononitro-naphthalimide conjugate with minimized side-effects targeting DNA damage response via a dual-DNA-damage approach to overcome cisplatin resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(1 citation statement)
references
References 81 publications
0
1
0
Order By: Relevance
“…Compounds containing a thiophene have exhibited diverse therapeutic properties, including anti-inflammatory, anti-psychotic, anti-anxiety, kinase inhibiting, and most importantly anti-cancer effects [ 5 ]. In the U.S. and Canada, thiophenes and their derivatives have demonstrated efficacy in treating diverse cancers and other clinical diseases [ 6 , 7 ]. For example, 2- Butylthiophene, a well-known thiophene has been used in the process of synthesizing anti-cancer agents.…”
Section: Introductionmentioning
confidence: 99%
“…Compounds containing a thiophene have exhibited diverse therapeutic properties, including anti-inflammatory, anti-psychotic, anti-anxiety, kinase inhibiting, and most importantly anti-cancer effects [ 5 ]. In the U.S. and Canada, thiophenes and their derivatives have demonstrated efficacy in treating diverse cancers and other clinical diseases [ 6 , 7 ]. For example, 2- Butylthiophene, a well-known thiophene has been used in the process of synthesizing anti-cancer agents.…”
Section: Introductionmentioning
confidence: 99%